Log In
BCIQ
Print this Print this
 

Aveed, Nebido, testosterone

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionLong-acting depot preparation of testosterone undecanoate
Molecular Target Not available
Mechanism of ActionHormone replacement therapy
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHypogonadism
Indication DetailsTreat male hypogonadism; Treat testosterone deficiency (hypogonadism)
Regulatory Designation
PartnerEndo International plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$637.0M

$370.0M

$267.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/23/2009

$637.0M

$370.0M

$267.0M

Get a free BioCentury trial today